Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients

PURPOSE OF REVIEW: Severe coronavirus disease 2019 (COVID-19) is characterized by the development of a deleterious hyperinflammatory response, in which the pleiotropic cytokine interleukin (IL)-6 plays a pivotal role. The administration of immunomodulatory therapies has been proposed to revert the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Ruiz, Mario, Aguado, José María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
COVID19 and Transplantation (R Avery, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581948/
https://www.ncbi.nlm.nih.gov/pubmed/33110739
http://dx.doi.org/10.1007/s40472-020-00306-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581948/
https://www.ncbi.nlm.nih.gov/pubmed/33110739
http://dx.doi.org/10.1007/s40472-020-00306-x

Ejemplares similares